News & Articles

The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus

Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Which new products made the most difference to your lab work this year?

Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

New kit is designed to enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

Our expert webinar series aims to help you get the most from your drug discovery research

A rare lung disease drug is being trialed to help fight COVID-19

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Assay will help guide treatment decisions in cases of non-small cell lung cancer

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development